Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. [electronic resource]
Producer: 20160512Description: e1005381 p. digitalISSN:- 1553-7374
- Adult
- Alkynes
- Anti-HIV Agents -- administration & dosage
- Benzoxazines -- administration & dosage
- CCR5 Receptor Antagonists -- administration & dosage
- Chromatography, High Pressure Liquid
- Cyclohexanes -- administration & dosage
- Cyclopropanes
- Drug Combinations
- Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination -- administration & dosage
- Enzyme-Linked Immunosorbent Assay
- Female
- Flow Cytometry
- HIV Infections -- drug therapy
- HIV Integrase Inhibitors -- administration & dosage
- Humans
- Immunity, Mucosal -- drug effects
- Lymphocyte Activation -- drug effects
- Male
- Maraviroc
- Pilot Projects
- Raltegravir Potassium -- administration & dosage
- T-Lymphocyte Subsets -- drug effects
- Triazoles -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.